Edge Wealth Management LLC Biogen Inc. Transaction History

Edge Wealth Management LLC

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 Apr 14, 2022	SELL	$193.77 - $244.14 $968 - $1,220	-5 Closed	0 $0
Q4 2021 Jan 21, 2022	SELL	$223.92 - $287.77 $15,002 - $19,280	-67 Reduced 93.06%	5 $1,000
Q4 2021 Jan 14, 2022	BUY	$223.92 - $287.77 $15,002 - $19,280	67 Added 1340.0%	72 $1,000
Q3 2021 Oct 13, 2021	BUY	$282.99 - $369.05 $1,414 - $1,845	5 New	5 $1,000
Q4 2019 Jan 29, 2020	SELL	$220.06 - $304.07 $55,015 - $76,017	-250 Closed	0 $0
Q1 2019 Apr 11, 2019	BUY	$216.71 - $338.96 $54,177 - $84,740	250 New	250 $59,000
Q2 2018 Jul 17, 2018	SELL	$257.52 - $306.91 $77,256 - $92,073	-300 Closed	0 $0
Q1 2018 Apr 05, 2018	BUY	$260.13 - $367.91 $78,039 - $110,373	300 New	300 $82,000

1,018

128M

1.22M

1.4M

Ticker BIIB
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 144,000,992
Market Cap $25B
Description
Biogen Inc. discovers, develops, manufactures, and delivers therapies for treating neurological and neurodegenerative diseases. The company offers TECFIDERA, VUMERITY, AVONEX, PLEGRIDY, TYSABRI, and FAMPYRA for multiple sclerosis (MS); SPINRAZA for spinal muscular atrophy; and FUMADERM to treat plaque psoriasis. It also provides BENEPALI, an eta...

Get notified when there are updates to the investment portfolio of Edge Wealth Management LLC, based on Form 13F filings with the SEC.

Stay updated on Edge Wealth Management LLC with notifications on news.